All uses of the OVA1, Overa, and ROMA tests are investigational, including but not limited to:preoperative evaluation of adnexal masses to triage for malignancy, OR
screening for ovarian cancer, OR
selecting patients for surgery for an adnexal mass, OR
evaluation of patients with clinical or radiologic evidence of malignancy, OR
evaluation of patients with nonspecific signs or symptoms suggesting possible malignancy, OR
postoperative testing and monitoring to assess surgical outcome and/or to detect recurrent malignant disease following treatment.